CLEPSO Meeting 2011 - Program

Please click on logo for meeting program in pdf format.

Day one, March 11th, 2011


Get together 10:30 h – 11:00 h



Ulrich Mahlknecht, Conference Organizer


 Welcome Speeches

11.00 h – 11:30 h

Michael Menger, Dean of the Faculty of Medicine, Saarland University

Volker Linneweber, Saarland University President

Peter Hauptmann, Secretary of State, Ministry of Science and Economy


 Keynote Speakers

11.30 h – 12:00 h

Lucia Altucci, University of Naples, Italy

Molecular Basis and Novel Options for Alternative Epigenetic Treatments Against Cancer


12:00 h – 12:30 h

James R. Davie, University of Manitoba, Canada

Histone Deacetylase 1 and 2: Distribution and Function in the Regulation of Gene Expression


12:30 h – 13:00 h

Marc Diederich, Fondation Recherche sur le Cancer et les Maladies du Sang, Luxemburg

Natural Compounds are Epigenetic Regulators of Leukemia Gene Expression


Lunch break 13:00 h – 14:00 h

14:00 h – 14:30 h

Karl Ekwall, Karolinska Institute, Sweden

Epigenetics of Cellular Differentiation.


14:30 h – 15:00 h

Nicole Engel, Ludwig Maximilian's University Munich, Germany

Epigenetic Approaches in Stem Cell Transplantation


15:00 - 15:30h

Igor Afanas'ev, Moscow, Russia

The Surviving/Death Effects of Reactive Oxygen Species in Cancer Cells


15:30 h – 16:00 h

Steven Gray, Trinity College, Dublin, Ireland

Epigenetic Treatment of Neurological Disease


Coffee break 16:00 h – 16:30 h

16:30 h – 17:00 h

Georges Herbein, University of Besancon, France

Epigenetic Regulation of HIV-1 Transcription


17:00 h – 17:30 h

Gordan Lauc and Vlatka Zoldos, Zagreb, Croatia

Epigenetics of Protein Glycosylation


17:30 h – 18:00 h

Manfred Jung, University of Freiburg, Germany

HDAC Inhibition - a Matter of Selectivity?!



20:00 h Dinner



Day two, March 12th, 2011

8:30 h – 9:00 h

Kevin Morris, La Jolla, CA, USA

The action of natural antisense non-coding RNAs in guiding epigenetic states in human cells


9:00 h – 9:30 h

Omar Khan, Oxford, UK

Clinical Application of HDAC Inhibitors


9:30 h – 10:00 h

Eckart Meese, Saarland University, Homburg, Germany

MicroRNA Expression Signatures of Tumor Patients


10:00 h – 10:30 h

Richard L Momparler, University of Montreal, Canada

Potential of 5-Aza-2'-deoxycytidine in Cancer Therapy


Coffee break 10:30 h – 11:00 h

 11:00 h – 11:30 h

Pamela Munster, University of California, San Francisco

Epigenetic Modulation to Reverse Hormonal Therapy Resistance


11:30 h – 12:00 h

Wolfgang Schulz, University of Düsseldorf, Germany

Selective Changes of Retroelement Expression in Human Prostate Cancer


12:00 h – 12:30 h

Stephen Nimer, Memorial Sloan-Kettering Cancer Center, New York

Epigenetics of Hematological Disease


Lunch break 12:30 h – 14:00 h

 14:00 h – 14:30 h

Christoph Plass, German Cancer Research Center (DKFZ), Heidelberg, Germany

Cancer Chemoprevention by Targeting the Epigenome


14:30 h – 15:00 h

Jörg Reichrath, Saarland University, Homburg, Germany

Epigenetic Modulation of Vitamin D Signaling in Melanoma Cells?


15:00 h – 15:30 h

Ed Seto, Moffitt Cancer Center, Tampa, Florida

Functions, Mechanisms of Action, and Regulations of HDACs


Coffee break 15:30 h – 16:00 h

 16:00 h – 16:30 h

Trygve Tollefsbol, University of Alabama, Birmingham, Alabama

Epigenetics as a Clinical Dietary-based Intervention in Aging and Cancer Prevention


16:30 h – 17:00 h

Jörn Walter, Saarland University, Saarbrücken, Germany

5-Hydroxymethyl-cytosine - a New Modification Important for Epigenetic Reprogramming


17:00  – 17:00 h

Ulrich Mahlknecht

Concluding remarks, end of congress